The two quantitative tools are built on the Volpara algorithm, which is designed to generate volumetric measurements, including density from both digital mammography and tomosynthesis images, as well as patient-specific dose and applied pressure.
Both products have received Europe's CE Mark and been cleared by the U.S. Food and Drug Administration (FDA), Health Canada, and Australia's Therapeutic Goods Administration (TGA).
VolparaAnalytics monitors and records elements of the breast imaging process, including mammography, tomosynthesis, and technologist performance. The software generates imaging performance metrics for technologists, readers, and mammography machines and presents the information inside a dashboard.
VolparaDose uses a standard mean glandular dose algorithm, along with patient-specific volumetric breast density, to better estimate the dose absorbed by a specific breast.